Download PDF@ http://www.marketsandmarkets.com/pdfdownload.asp?id=172240059 The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

1. Clinical Trial Supplies Market worth 1.2 Billion USD
by 2020
The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution,
Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic
Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides
a detailed overview of the major drivers, restraints, challenges, opportunities, current market
trends, and strategies impacting the clinical trial supplies market along with the estimates and
forecasts of the revenue and market share analysis.
Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial
Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging
and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental
Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-
172240059.html.
The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from
USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.
The report segments this market based on products and services, phases, therapeutic areas,
and regions. Among the various products and services, the logistics and distribution services
segment is expected to account for the largest share of the market and is projected to grow at
the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the
factors such as globalization of clinical trials and increasing outsourcing of services.
On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and
phase III. The phase III segment is expected to account for the largest share of the global clinical
trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are
the factors propelling the growth of this market.
Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular
diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood
disorders, infectious diseases, and others. The oncology segment is expected to account for the
largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences
and government funding for cancer research are factors driving the growth of this market.
Based on regions, the global clinical trial supplies market is segmented into North America,
Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for

2. the largest share of the market during the forecast period. Growth in this regional segment is
driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials,
and the increasing number of life sciences research activities in North America.
Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.),
Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services
(U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services
(U.S.), and Thermo Fisher Scientific, Inc. (U.S.)
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200 premium
studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals.
We specialize in consulting assignments and business research across high growth markets,
cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high growth markets following the "Growth
Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write "Attack, avoid and
defend" strategies, identify sources of incremental revenues for both the company and its
competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over
200,000 markets and entire value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets. The new included chapters on Methodology
and Benchmarking presented with high quality analytical infographics in our reports gives
complete visibility of how the numbers have been arrived and defend the accuracy of the
numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business
insight with our huge market intelligence repository.
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com